CRISPR Therapeutics AG

NASDAQ:CRSP

41.99 (USD) • At close March 13, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

20242023202220212020201920182017201620152014
Revenue 35371.2060.436913.0810.543289.593.12440.9975.1640.2470
Cost of Revenue -2.314130.25110.2517.953269.407179.362113.77369.842.23812.5731.513
Gross Profit 37.314240.956-109.814895.128-268.864110.228-110.649-28.803-37.074-12.326-1.513
Gross Profit Ratio 1.0660.649-251.8670.98-495.1450.381-35.419-0.703-7.179-49.9030
Reseach & Development Expenses 320.653387.332461.645438.633266.946179.362113.77369.842.23812.5731.513
General & Administrative Expenses 72.97776.162102.464102.80288.20863.48848.29435.84531.05613.4035.114
Selling & Marketing Expenses 00000000000
SG&A 72.97776.162102.464102.80288.20863.48848.29435.84531.05613.4035.114
Other Expenses 110.25-1.206-0.762-1.882-0.17620.566-5.485-0.19778.5120.016-0.236
Operating Expenses 503.88462.288563.347539.553354.978242.85162.067105.64573.29425.9766.627
Operating Income -466.566-222.538-673.161373.528-354.43546.74-158.943-64.648-68.13-25.729-6.627
Operating Income Ratio -13.33-0.6-1,543.9470.409-652.7350.161-50.878-1.577-13.193-104.1660
Total Other Income Expenses Net 103.90171.81622.6616.0036.37920.566-5.485-1.9645.412-0.092-0.236
Income Before Tax -362.665-150.722-650.5379.531-348.05667.306-164.428-66.608-22.718-25.821-6.863
Income Before Tax Ratio -10.362-0.406-1,491.9720.416-640.9870.232-52.634-1.625-4.399-104.5380
Income Tax Expense 3.5872.888-0.3251.870.8090.4480.5531.7490.4840.007-0.063
Net Income -366.252-153.61-650.175377.661-348.86566.858-164.981-68.357-23.202-25.828-6.8
Net Income Ratio -10.464-0.414-1,491.2270.414-642.4770.231-52.811-1.667-4.493-104.5670
EPS -4.34-1.94-8.364.97-5.291.23-3.44-1.71-1.89-0.88-0.23
EPS Diluted -4.34-1.94-8.364.7-5.291.17-3.44-1.71-1.89-0.88-0.23
EBITDA -466.566-202.701-648.989391.481-345.25151.465-155.424-61.624-13.668-25.586-6.589
EBITDA Ratio -13.33-0.546-1,543.9470.409-635.8210.161-50.878-1.503-4.885-103.5870